We investigated the relationship between METTL7A and various clinical subgroups in KIRC and found that the expression of METTL7A was significantly related to tumor stage (T stage), metastasis stage (M stage), pathologic stage, primary therapy outcome, histologic grade, and gender of KIRC (Table 1). The gene discussed is TMT1A; the disease is neoplasm.